Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE987B01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Natco Pharma L Natco Pharma Ltd. | BSE 892.85 -5.95 (-0.66%) | NSE 892.80 -4.95 (-0.55%) | Trade | Add

BSE Live

Dec 09, 16:01

892.85 -5.95 (-0.66%)

Volume

AVERAGE VOLUME

5-Day

193,826

10-Day

363,453

30-Day

163,108

71,313

Prev. Close

898.80
Open Price

891.20

Bid Price (Qty.)
892.85 (5)
Offer Price (Qty.)
898.00 (62)

NSE Live

Dec 09, 15:58

892.80 -4.95 (-0.55%)

Volume

AVERAGE VOLUME

5-Day

1,391,915

10-Day

4,793,556

30-Day

2,234,009

703,288

Prev. Close

897.75
Open Price

895.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
892.80 (25)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Natco Pharma (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	1,887.80	2,046.80	2,167.70	2,032.80	1,056.60
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	17.20	44.80	37.80
Revenue From Operations [Net]	1,887.80	2,046.80	2,150.50	1,988.00	1,018.80
Total Operating Revenues	1,915.00	2,094.50	2,184.80	2,020.20	1,042.30
Other Income	107.40	130.20	40.40	13.90	9.60
Total Revenue	2,022.40	2,224.70	2,225.20	2,034.10	1,051.90
EXPENSES
Cost Of Materials Consumed	329.00	333.10	390.50	520.80	303.70
Purchase Of Stock-In Trade	127.80	55.00	45.90	97.10	15.20
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FGWIP And Stock In Trade	-75.20	-33.90	-25.30	-18.80	-48.30
Employee Benefit Expenses	375.00	355.90	325.60	243.20	179.80
Finance Costs	21.50	19.30	15.40	18.50	22.90
Depreciation And Amortisation Expenses	99.80	81.00	66.20	54.40	50.80
Other Expenses	575.80	589.60	519.70	494.50	326.30
Total Expenses	1,453.70	1,400.00	1,338.00	1,409.70	850.40
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	568.70	824.70	887.20	624.40	201.50
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	568.70	824.70	887.20	624.40	201.50
Tax Expenses-Continued Operations
Current Tax	127.10	188.30	219.90	135.40	44.10
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-20.50	-6.00	-27.90	0.10	3.80
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	110.60	182.30	192.00	139.50	47.90
Profit/Loss After Tax And Before ExtraOrdinary Items	458.10	642.40	695.20	484.90	153.60
Profit/Loss From Continuing Operations	458.10	642.40	695.20	484.90	153.60
Profit/Loss For The Period	458.10	642.40	695.20	484.90	155.80
Minority Interest	2.70	2.00	1.00	1.10	1.30
Consolidated Profit/Loss After MI And Associates	460.80	644.40	696.20	486.00	157.10
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	25.00	35.00	39.00	28.00	9.00
Diluted EPS (Rs.)	25.00	35.00	39.00	28.00	9.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	127.40	91.90	150.90	117.60	21.80
Tax On Dividend	26.20	18.90	30.80	24.00	4.40